Primary Care
pneumococcal vaccine acip :: Article Creator ACIP Expands Pneumococcal Conjugate Vaccine Recommendations The Centers for Disease Control and Prevention (CDC)'s Advisory Committee on Immunization Practices (ACIP) has expanded age-based recommendations for pneumococcal conjugate vaccines (PCVs), with a single dose now indicated for vaccine-naive adults aged 50 years and older. The updated recommendations were published in Morbidity and Mortality Weekly Report. The ACIP of the CDC previously recommended a single dose of PCV for all adults aged 65 years and older and for those aged between 19 and 64 years at increased risk for disease who have no history or an unknown history of vaccination. In a June 2024 meeting, they suggested PCV21 as an option for vaccine-naive adults and proposed a review of available evidence to determine whether data supported an expansion of age-based PCV recommendations. The ACIP Pneumococcal Vaccines Work Group then m...